Organization
Acumen Pharmaceuticals
2 clinical trials
3 abstracts
Clinical trial
A Phase 2/3 Double-Blind, Randomized, Placebo-Controlled Adaptive Design Trial to Evaluate the Efficacy and Safety of Intravenous ACU193 in Early Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2031-01-01
Clinical trial
A Phase 1 Placebo-Controlled, Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous ACU193 in Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2023-06-12
Abstract
ADAPTATION OF THE EDUCATIONAL NEEDS ASSESSMENT TOOL FOR USE IN 4 EUROPEAN COUNTRIESOrg: Acumen Pharmaceuticals, University of Leeds, Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, Barnsley District Hospital,
Abstract
A SURVEY OF THE ROLE OF THE CLINICAL NURSE SPECIALIST IN THE UK - HAS IT CHANGED OVER THE LAST DECADE?Org: Staffordshire Rheumatology Centre, Haywood Hospital, Stoke on Trent, Acumen Pharmaceuticals, Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom,
Abstract
AN OVERVIEW OF THE NURSE LED CLINIC AND THE POTENTIAL TO IMPROVE EARLY ACCESS TO CARE Org: Acumen Pharmaceuticals, University of Leeds, Leeds Children's Hospital, Leeds General Infirmary,